RTI Surgical Holdings Inc. (RTIX)

4.37
0.03 0.68
NASDAQ : Health Technology
Prev Close 4.40
Open 4.40
Day Low/High 4.32 / 4.50
52 Wk Low/High 3.51 / 6.15
Volume 134.62K
Avg Volume 256.10K
Exchange NASDAQ
Shares Outstanding 73.90M
Market Cap 334.01M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Ratings Changes To Be Publicly Issued on 5/30/13

Upgrades: ACM, ATEC, BYD, DLB, EJ, GGS, ITI, KTOS, PERY, RTIX, UPS, ZEP Downgrades: ASFI, DLLR, FURX, GLPW, GNMK, NPK, PESI, SPSC, XNY Initiations: ACRE, EDG, FRGI Read on to get TheStreet Quant Ratings' detailed report:

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look poised to trade higher from current levels.

3 Health Care Stocks Under $10 to Watch

3 Health Care Stocks Under $10 to Watch

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

RTI Biologics Announces Positive Clinical Results For BioCleanse®-Processed BTB Allografts Used In ACL Reconstruction

RTI Biologics Announces Positive Clinical Results For BioCleanse®-Processed BTB Allografts Used In ACL Reconstruction

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, is pleased to announce the results of a recent randomized prospective clinical study of...

RTI Biologics® Receives 510(k) Clearance For Porcine Dermis Implant

RTI Biologics® Receives 510(k) Clearance For Porcine Dermis Implant

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, is pleased to announce that the company has received 510(k) clearance from the U.

RTI Biologics Launches New Line Of Biologic Implants At Americas Hernia Society’s 15th Annual Hernia Repair Conference, March 13-16

RTI Biologics Launches New Line Of Biologic Implants At Americas Hernia Society’s 15th Annual Hernia Repair Conference, March 13-16

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, is launching a new line of biologic implants used in hernia repair procedures at the Americas Hernia...

RTI Biologics Inc. Stock Downgraded (RTIX)

RTI Biologics Inc. Stock Downgraded (RTIX)

RTI Biologics (Nasdaq:RTIX) has been downgraded by TheStreet Ratings from from a buy to hold.

RTI Biologics Announces 2012 Fourth Quarter, Full Year Results, 2013 Financial Guidance

RTI Biologics Announces 2012 Fourth Quarter, Full Year Results, 2013 Financial Guidance

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the fourth quarter and full year of 2012 as follows: Quarterly...

RTI Biologics Schedules 2012 Fourth Quarter, Year End Earnings And Conference Call For February 7, 2013

RTI Biologics Schedules 2012 Fourth Quarter, Year End Earnings And Conference Call For February 7, 2013

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the fourth quarter and year end 2012 on Thursday,...

Representatives From RTI Biologics, Inc., CPPI, And RS&H Break Ground On The New Logistics And Technology Center At The Alachua, Fla. Headquarters. (Photo: Business Wire)

Representatives From RTI Biologics, Inc., CPPI, And RS&H Break Ground On The New Logistics And Technology Center At The Alachua, Fla. Headquarters. (Photo: Business Wire)

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a provider of orthopedic and other biologic implants, celebrated the ground breaking of its new 41,165-square-foot Logistics and Technology Center on Monday, Jan.

RTI Biologics Inc. Stock Upgraded (RTIX)

RTI Biologics Inc. Stock Upgraded (RTIX)

RTI Biologics (Nasdaq:RTIX) has been upgraded by TheStreet Ratings from a hold to buy.

RTI Biologics® Announces Launch Of BioReady™ DBM Putty

RTI Biologics® Announces Launch Of BioReady™ DBM Putty

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, is launching a new biologic implant for use in sports medicine, orthopedic ...

RTI Biologics Announces 2012 Third Quarter Results

RTI Biologics Announces 2012 Third Quarter Results

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the third quarter of 2012 as follows: Quarterly Highlights: ...

RTI Biologics Schedules 2012 Third Quarter Earnings And Conference Call For October 25, 2012

RTI Biologics Schedules 2012 Third Quarter Earnings And Conference Call For October 25, 2012

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the third quarter on Thursday, Oct.

Nalleli Fernandez, Center, With Her Family At CURE Honduras, San Pedro Sula, Honduras, On Sept. 18, 2012. Photo Is Courtesy Of CURE International.

Nalleli Fernandez, Center, With Her Family At CURE Honduras, San Pedro Sula, Honduras, On Sept. 18, 2012. Photo Is Courtesy Of CURE International.

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, recently donated several BioSet® RT Allograft Paste implants to Lemoyne, Pa.

RTI Biologics Announces 2012 Second Quarter Results

RTI Biologics Announces 2012 Second Quarter Results

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the second quarter of 2012 as follows: Quarterly Highlights: ...

RTI Biologics Schedules 2012 Second Quarter Earnings And Conference Call For July 31, 2012

RTI Biologics Schedules 2012 Second Quarter Earnings And Conference Call For July 31, 2012

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the second quarter on Tuesday, July 31, 2012 prior...

RTI Biologics Announces 2012 First Quarter Results

RTI Biologics Announces 2012 First Quarter Results

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the first quarter of 2012 as follows: Quarterly Highlights: ...

RTI Biologics Schedules 2012 First Quarter Earnings And Conference Call For April 26, 2012

RTI Biologics Schedules 2012 First Quarter Earnings And Conference Call For April 26, 2012

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the first quarter on Thursday, April 26, 2012 prior...

RTI Biologics Highlights Biologic Implants, Public Education Website At 2012 American Academy Of Orthopaedic Surgeons (AAOS) Annual Meeting

RTI Biologics Highlights Biologic Implants, Public Education Website At 2012 American Academy Of Orthopaedic Surgeons (AAOS) Annual Meeting

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, is highlighting two new allografts and introducing a public education website at the American Academy of...

RTI Biologics Inc. Stock Downgraded (RTIX)

RTI Biologics Inc. Stock Downgraded (RTIX)

RTI Biologics (Nasdaq:RTIX) has been downgraded by TheStreet Ratings from from a buy to hold.

RTI Biologics Announces 2011 Fourth Quarter, Full Year Results, 2012 Financial Guidance

RTI Biologics Announces 2011 Fourth Quarter, Full Year Results, 2012 Financial Guidance

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the fourth quarter and full year of 2011 as follows: Quarterly...

RTI Biologics Schedules 2011 Fourth Quarter Earnings And Conference Call For Jan. 31, 2012

RTI Biologics Schedules 2011 Fourth Quarter Earnings And Conference Call For Jan. 31, 2012

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the fourth quarter on Tuesday, Jan.

RTI Biologics Launches AllograftInfo.com Educational Website

RTI Biologics Launches AllograftInfo.com Educational Website

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, has launched an informational website to educate patients and the general public about allograft tissue.

RTI Biologics Achieves 98.7 Percent Equipment Performance Rating – Recognized In Evolution Magazine

RTI Biologics Achieves 98.7 Percent Equipment Performance Rating – Recognized In Evolution Magazine

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, was recognized in the 2011 fourth edition of Evolution magazine for achieving a 98.

Affordable Health Care

Demand for health care and medical supplies will likely rise as the population ages.

RTI Biologics Announces 2011 Third Quarter Results

RTI Biologics Announces 2011 Third Quarter Results

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the third quarter of 2011 as follows: Quarterly Highlights: ...

RTI Biologics Schedules 2011 Third Quarter Earnings And Conference Call For Oct. 27, 2011

RTI Biologics Schedules 2011 Third Quarter Earnings And Conference Call For Oct. 27, 2011

RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, announced today that it plans to release financial results from the third quarter on Thursday, Oct.

5 Stocks Poised for Breakouts

5 Stocks Poised for Breakouts

These stocks look to be setting up to break out and trade higher from current levels.

RTI Biologics Announces 2011 Second Quarter Results

RTI Biologics Announces 2011 Second Quarter Results

RTI Biologics Inc. (RTI) (Nasdaq: RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the second quarter of 2011 as follows: Quarterly Highlights: ...

TheStreet Quant Rating: C (Hold)